- Home
- TVRD vs LEGT Comparison
TVRD vs LEGT Comparison
Compare TVRD & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- LEGT
- Stock Information
- Founded
- TVRD 2017
- LEGT 2023
- Country
- TVRD United States
- LEGT United States
- Employees
- TVRD N/A
- LEGT N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- LEGT
- Sector
- TVRD Health Care
- LEGT
- Exchange
- TVRD Nasdaq
- LEGT Nasdaq
- Market Cap
- TVRD 246.5M
- LEGT 277.1M
- IPO Year
- TVRD N/A
- LEGT 2024
- Fundamental
- Price
- TVRD $40.68
- LEGT $10.74
- Analyst Decision
- TVRD Strong Buy
- LEGT
- Analyst Count
- TVRD 5
- LEGT 0
- Target Price
- TVRD $59.20
- LEGT N/A
- AVG Volume (30 Days)
- TVRD 67.6K
- LEGT 17.9K
- Earning Date
- TVRD 11-21-2025
- LEGT 01-01-0001
- Dividend Yield
- TVRD N/A
- LEGT N/A
- EPS Growth
- TVRD N/A
- LEGT N/A
- EPS
- TVRD N/A
- LEGT 0.35
- Revenue
- TVRD N/A
- LEGT N/A
- Revenue This Year
- TVRD N/A
- LEGT N/A
- Revenue Next Year
- TVRD N/A
- LEGT N/A
- P/E Ratio
- TVRD N/A
- LEGT $30.60
- Revenue Growth
- TVRD N/A
- LEGT N/A
- 52 Week Low
- TVRD $8.13
- LEGT $10.18
- 52 Week High
- TVRD $42.10
- LEGT $10.86
- Technical
- Relative Strength Index (RSI)
- TVRD 70.68
- LEGT 50.70
- Support Level
- TVRD $36.05
- LEGT $10.72
- Resistance Level
- TVRD $42.10
- LEGT $10.74
- Average True Range (ATR)
- TVRD 2.87
- LEGT 0.01
- MACD
- TVRD 0.07
- LEGT -0.00
- Stochastic Oscillator
- TVRD 82.26
- LEGT 33.33
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.